SCHEMBL16850112

SCHEMBL16850112

c1ccc(-n2c3ccccc3c3cc(-c4ccc5c(c4)c4ccccc4n5-c4ccc(-c5cc6c7ccccc7n7c8ccccc8c(c5)c67)cc4)ccc32)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.53
KDM4E B2RXH2 1/20 0.53
ATM Q13315 1/20 0.53
HDAC4 P56524 1/20 0.40
TSPO P30536 2/20 0.38
PTGER4 P35408 1/20 0.36
KMT2A Q03164 3/20 0.35
IL1R1 P14778 1/20 0.35
AKR1C4 P17516 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
AKR1C1 Q04828 1/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
POLB P06746 1/20 0.34
TSHR P16473 1/20 0.34
BRCA1 P38398 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16850123 1.00 L3MBTL1 (0.53) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL16850097 1.00 L3MBTL1 (0.53) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL17776504 0.98 L3MBTL1 (0.55) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL25480059 0.97 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL16850102 0.97 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL23823895 0.97 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL16850120 0.97 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL16850121 0.97 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL17146740 0.97 L3MBTL1 (0.56) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL17265127 0.97 L3MBTL1 (0.56) L3MBTL1KDM4EATMHDAC4TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220216426-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2022-07-07 US disclosed
US-20150179955-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-06-25 US disclosed
US-20150179955-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220216426-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS NCL, DNMT3A, NUDT1 L3MBTL1 2269/4885KDM4E 3514/4885ATM 666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.